Our prediction of the chemokine (C-X-C motif) ligand 1 and 2 (CXCL1, CXCL2) as direct and indirect downstream targets of NFκB in prostate cancer can be supported by previous finding in different contexts [7,51,65,66]. This evidence concerns the gene NFKB1 and prostate cancer.